Coca-Cola is nearing a deal to buy a controlling stake in sports drink maker BodyArmor for $8 billion, which could be announced as early as Monday.
The late basketball icon Kobe Bryant was among BodyArmor’s earliest investors, buying a stake in 2013, just two years after it was launched.
According to Coca-Cola, it would not comment on the deal, regarding it as a mere rumor or speculation.
Coca-Cola bought a minority stake in BodyArmor in 2018 to become the brand’s second-largest shareholder.
The beverage giant has been focusing on its fast-moving beverages as consumers who are coming out of the come out of the pandemic are picking up more of its traditional sodas and flavored sparkling waters.
The company discontinued its Coca-Cola Energy drink in North America in May but kept its majority stake in Monster Beverage, one of the top energy drinks in the US.In 2018, Coca-Cola acquired coffee chain Costa for $5.1 billion to mark both a push into the coffee market and its first foray into retail chain operations.


Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears
Why Manchester City offered Erling Haaland the longest contract in Premier League history
Apple Eyes U.S. Formula 1 Broadcast Rights in Major Sports Streaming Push
Trump Threatens Stadium Deal Over Washington Commanders Name
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Trump to Host UFC Event at White House on His 80th Birthday
Trump Plans UFC Event at White House for America’s 250th Anniversary
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 



